Purchase Order HHSI245201600925P
- Not listed
- This is a Delivery Order (DO) awarded by the Indian Health Service (IHS), a civilian agency within the U.S. Department of Health and Human Services, to Biofire Diagnostics LLC. The DO is for COVID-19 testing panels and kits, and is issued under an Indefinite Delivery, Indefinite Quantity (IDIQ) contract. The total ceiling value of this order is $68,984. Biofire Diagnostics LLC is a foreign-owned, for-profit biotech company that specializes in syndromic infectious disease testing. This order does...
- This is a $286,617.93 firm fixed-price purchase order contract awarded by the U.S. Department of Health and Human Services Indian Health Service to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, for cost per test and supplies. The contract has a period of performance through July 31, 2023 and does not have a set-aside designation. Biofire Diagnostics LLC is a leader in syndromic infectious disease testing and has received numerous federal contracts and task orders to...
- This is a firm fixed-price purchase order awarded by the Indian Health Service, a civilian agency within the U.S. Department of Health and Human Services, to Biofire Diagnostics LLC for the provision of a BIOFIRE ANALYZER, KITS AND PANELS, and UNO SERVICE UNIT to support COVID-19 response efforts. The award, valued at $57,100.00, has an ultimate completion date of October 31, 2021. Biofire Diagnostics LLC is a foreign-owned, for-profit organization that specializes in syndromic infectious...
- This federal contract award to Biofire Diagnostics LLC, a biotech company specializing in infectious disease testing, is for the purchase of BioFire FilmArray-Molecular equipment with a torch base and four years of warranty coverage. The $306,900.00 firm fixed-price purchase order was issued by the Indian Health Service (IHS), a civilian agency within the Department of Health and Human Services. No set-aside designation was used. The award stems from a solicitation for BioFire...
- This federal contract award was issued by the Veterans Integrated Service Network 8 (VISN 8), a component of the Department of Veterans Affairs (VA) Veterans Health Administration (VHA), to Biofire Diagnostics LLC, a private sector biotech company. The contract provides for the delivery of molecular diagnostic testing services and products, including COVID-19 testing reagents and equipment, as well as maintenance services for Biofire's infectious disease testing systems. The contract is a...
- This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company that specializes in infectious disease testing. The $110,160.00 firm-fixed-price purchase order was issued under the VA VISN 9 network for COVID-19 panel testing using Biofire's 423738 COVID emergency testing products. No set-aside was used. Biofire Diagnostics has held numerous federal contracts with the VA,...
- This federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing, is for $801,960.90 to provide "Molecular Pathogen Detection" services. The contract was awarded by the Veterans Health Administration (VHA), part of the Department of Veterans Affairs (VA), and is not set aside. The contract is a Blanket Purchase Agreement (BPA) call against Biofire's General Services Administration (GSA) Federal Supply Schedule contract for...
- This federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing, is for a Blanket Purchase Agreement (BPA) call under their existing General Services Administration (GSA) Federal Supply Schedule 65-VII contract for in vitro diagnostics, reagents, and tests. The contract is with the Veterans Health Administration (VHA) within the Department of Veterans Affairs and has a ceiling value of $171,925.20. It is for the provision of...
- This federal contract award was made by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The $84,000 firm-fixed-price delivery order was awarded against Biofire's General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. The contract is for FILM ARRAY AND ASSY, which likely refers to diagnostic testing...
- This federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing, is for MOLECULAR PATHOGEN DETECTION services. The $54,219.13 firm fixed price award was made against Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents and tests. No set-aside was used. The contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA),...
This federal contract award was made by the Indian Health Service (IHS), a civilian agency within the U.S. Department of Health and Human Services, to Biofire Diagnostics LLC, a biotech company that specializes in syndromic infectious disease testing. The contract, valued at $92,180.60, is for the purchase of Biofire diagnostic products and services, including molecular diagnostic testing services, COVID-19 testing reagents and equipment, and maintenance services for Biofire systems. The contract is a firm fixed-price purchase order without any set-aside designation. Biofire Diagnostics LLC holds several indefinite delivery contracts and blanket purchase agreements with various Veterans Integrated Service Networks (VISNs) within the Department of Veterans Affairs (VA) Veterans Health Administration (VHA), as well as with the Department of Health and Human Services Indian Health Service, for the provision of Biofire's infectious disease testing products and services on an as-needed basis. These include a $1.6 million initial delivery order under a VISN 10 contract, a five-year VISN 19 blanket purchase agreement with a potential value of up to $650,000, and a VISN 1 blanket purchase agreement with a potential value of up to $6 million for COVID-19 testing reagents and equipment.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 1 | Other Administrative Action | $0 | 6/7/16 | |
| Not listed | Not listed | $92.2k | 6/3/16 |